Correlation Between Shuttle Pharmaceuticals and Procaps Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shuttle Pharmaceuticals and Procaps Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shuttle Pharmaceuticals and Procaps Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shuttle Pharmaceuticals and Procaps Group SA, you can compare the effects of market volatilities on Shuttle Pharmaceuticals and Procaps Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shuttle Pharmaceuticals with a short position of Procaps Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shuttle Pharmaceuticals and Procaps Group.

Diversification Opportunities for Shuttle Pharmaceuticals and Procaps Group

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Shuttle and Procaps is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Shuttle Pharmaceuticals and Procaps Group SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Procaps Group SA and Shuttle Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shuttle Pharmaceuticals are associated (or correlated) with Procaps Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Procaps Group SA has no effect on the direction of Shuttle Pharmaceuticals i.e., Shuttle Pharmaceuticals and Procaps Group go up and down completely randomly.

Pair Corralation between Shuttle Pharmaceuticals and Procaps Group

Given the investment horizon of 90 days Shuttle Pharmaceuticals is expected to under-perform the Procaps Group. But the stock apears to be less risky and, when comparing its historical volatility, Shuttle Pharmaceuticals is 2.68 times less risky than Procaps Group. The stock trades about -0.17 of its potential returns per unit of risk. The Procaps Group SA is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  189.00  in Procaps Group SA on August 28, 2024 and sell it today you would lose (62.00) from holding Procaps Group SA or give up 32.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Shuttle Pharmaceuticals  vs.  Procaps Group SA

 Performance 
       Timeline  
Shuttle Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Procaps Group SA 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Procaps Group SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Procaps Group exhibited solid returns over the last few months and may actually be approaching a breakup point.

Shuttle Pharmaceuticals and Procaps Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shuttle Pharmaceuticals and Procaps Group

The main advantage of trading using opposite Shuttle Pharmaceuticals and Procaps Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shuttle Pharmaceuticals position performs unexpectedly, Procaps Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procaps Group will offset losses from the drop in Procaps Group's long position.
The idea behind Shuttle Pharmaceuticals and Procaps Group SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas